CoChat

Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators

Open access
Task force members, Vijgen, J., Botto, G., Camm, J., Hoijer, C.-J., Jung, W., Le Heuzey, J.-Y., Lubinski, A., Norekval, T. M., Santomauro, M., Schalij, M., Schmid, J.-P., Vardas, P. · 2009 · Europace
Cited by 98

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Abstract Patients with an implantable cardioverter defibrillator (ICD) have an ongoing risk of sudden incapacitation that might cause harm to others while driving a car. Driving restrictions vary across different countries in Europe. The most recent recommendations for driving of ICD patients in Europe were published in 1997 and focused mainly on patients implanted for secondary prevention. In recent years there has been a vast increase in the number of patients with an ICD and in the percentage of patients implanted for primary prevention. The EHRA task force on ICD and driving was formed to reassess the risk of driving for ICD patients based on the literature available. The recommendations are summarized in the following table and are further explained in the document. Restriction for private drivingRestriction for professional drivingICD implantation for secondary preventionThree monthsPermanentICD implantation for primary preventionFour weeksPermanentAfter appropriate ICD therapyThree monthsPermanentAfter inappropriate ICD therapyUntil measures to prevent inappropriate therapy are takenPermanentAfter replacement of the ICDOne weekPermanentAfter replacement of the lead systemFour weeksPermanentPatients refusing ICD for primary preventionNo restrictionPermanentPatients refusing ICD implantation for secondary preventionSeven monthsPermanentDriving restrictions are perceived as difficult for patients and their families, and have an immediate consequence for their lifestyle. To increase the adherence to the driving restrictions, adequate discharge of education and follow-up of patients and family are pivotal. The task force members hope this document may serve as an instrument for European and national regulatory authorities to formulate uniform driving regulations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/europace/eup112

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 84

  1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators, 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal sustained ventricular arrhythmias, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 · DOI · Paper page
  2. Connolly, 2000, Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, 1297, 10.1161/01.CIR.101.11.1297 · DOI · Paper page
  3. Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 · DOI · Paper page
  4. Bigger, 1997, Prophylactic use of implantable cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery, N Engl J Med, 337, 1569, 10.1056/NEJM199711273372201 · DOI · Paper page
  5. Moss, 2002, Prophylactic implantation of defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 · DOI · Paper page
  6. Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 · DOI · Paper page
  7. Hammill, 2008, National ICD Registry Annual Report 2007: review of the Registry's Second Year, data collected, and plans to add lead and pediatric ICD procedures, Heart Rhythm, 5, 1359, 10.1016/j.hrthm.2008.07.015 · DOI
  8. Ector, 2007, Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association, Eur Heart J, 9, I44, 10.1093/eurheartj/sum062 · DOI
  9. Proclemer, 2009, Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005–07, Europace, 11, 465, 10.1093/europace/eun370 · DOI
  10. Peinado, 2008, Spanish implantable cardioverter-defibrillator registry. Fourth official report of the Spanish society of cardiology working group on implantable cardioverter-defibrillators, Rev Esp Cardiol, 61, 1191
  11. Anderson, 1994, Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator, Am Heart J, 127, 1185, 10.1016/0002-8703(94)90108-2 · DOI
  12. Baker, 1970, An evaluation of the hazard created by natural death at the wheel, N Engl J Med, 283, 405, 10.1056/NEJM197008202830806 · DOI
  13. Berger, 2002, Reporting by physicians of impaired drivers and potentially impaired drivers. The Committee on Bioethical Issues of the Medical Society of the State of New York, J Gen Intern Med, 15, 667, 10.1046/j.1525-1497.2000.04309.x · DOI
  14. Binns, 2000, Driving and arrhythmias, BMJ, 324, 927, 10.1136/bmj.324.7343.927 · DOI
  15. Grubb, 2007, Driving and implantable cardioverter-defibrillator; a clearer view, J Am Coll Cardiol, 50, 2241, 10.1016/j.jacc.2007.08.037 · DOI
  16. Bleakley, 2003, Driving and arrhythmias: implications of new data, Card Electrophysiol Rev, 7, 77, 10.1023/A:1023655410200 · DOI
  17. Blitzer, 2003, Causes of impaired consciousness while driving a motorized vehicle, Am J Cardiol, 91, 1373, 10.1016/S0002-9149(03)00336-9 · DOI
  18. Christian, 1988, Incidence and implications of natural deaths of road users, BMJ, 297, 1021, 10.1136/bmj.297.6655.1021 · DOI
  19. Finch, 1993, Driving safety among patients with automatic implantable cardioverter defibrillators, JAMA, 270, 1587, 10.1001/jama.1993.03510130093037 · DOI
  20. Craney, 1995, Factors related to driving in persons with an implantable cardioverter defibrillator, Prog Cardiovasc Nurs, 10, 12
  21. Jung, 1996, European policy on driving for patients with implantable cardioverter defibrillators, Pacing Clin Electrophysiol, 19, 981, 10.1111/j.1540-8159.1996.tb03396.x · DOI
  22. Jung, 1996, Quality of life and driving in recipients of the implantable cardioverter-defibrillator, Am J Cardiol, 78, 51, 10.1016/S0002-9149(96)00502-4 · DOI
  23. Smith, 2001, Driving after ventricular arrhythmias, N Engl J Med, 345, 451, 10.1056/NEJM200108093450609 · DOI
  24. Gimbel, 2004, When should patients be allowed to drive after ICD implantation?, Cleve Clin J Med, 71, 125, 10.3949/ccjm.71.2.125 · DOI
  25. Hartenbaum, 2005, What are the current guidelines on the use of implantable defibrillators in transportation safety critical work?, J Occup Environ Med, 47, 752
  26. Assessment of the cardiac patient for fitness to drive., 1992, Can J Cardiol, 8, 406
  27. Assessment of the cardiac patient for fitness to drive: 1996 update., 1996, Can J Cardiol, 12, 1164
  28. Jung, 1996, Driving and the implantable cardioverter defibrillator. Study Group on ICD and Driving, Lancet, 348, 687, 10.1016/S0140-6736(05)65114-8 · doi:10.1016/s0140-6736(05)65114-8
  29. Jung, 1997, Study Group on ‘ICD and Driving’ of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology, Eur Heart J, 18, 1210, 10.1093/oxfordjournals.eurheartj.a015432 · DOI · Paper page
  30. Petch, 1998, Driving and heart disease, Eur Heart J, 19, 1165
  31. Simpson, 2007, Can J Cardiol, 1313
  32. Epstein, 2007, A Scientific Statement from the American Heart Association and the Heart Rhythm Society, Circulation, 115, 1170, 10.1161/CIRCULATIONAHA.106.180203 · DOI · Paper page
  33. Sears, 1999, Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review, Clin Cardiol, 22, 481, 10.1002/clc.4960220709 · DOI · Paper page
  34. Finch, 1993, Driving safety among patients with automatic implantable cardioverter defibrillators, JAMA, 270, 1587, 10.1001/jama.1993.03510130093037 · DOI
  35. Dunbar, 2005, Psychosocial issues of patients with implantable cardioverter defibrillators, Am J Crit Care, 14, 294, 10.4037/ajcc2005.14.4.294 · DOI
  36. Carroll, 2008, Long-term effects of implanted cardioverter-defibrillators on health status, quality of life, and psychological state, Am J Crit Care, 17, 222, 10.4037/ajcc2008.17.3.222 · DOI
  37. James, 2001, The experiences of ICD patients and their partners with regards to adjusting to an imposed driving ban: a qualitative study, Coronary Health Care, 5, 80, 10.1054/chec.2001.0124 · DOI
  38. Eckert, 2002, How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families?, Intern J Nursing Practice, 8, 152, 10.1046/j.1440-172X.2002.00357.x · DOI · Paper page
  39. Fridlund, 2000, Patients with implantable cardioverter-defibrillators and their conceptions of the life situation: a qualitative analysis, J Clin Nursing, 9, 37, 10.1046/j.1365-2702.2000.00335.x · DOI
  40. Craney, 1995, Factors related to driving in persons with an implantable cardioverter defibrillator, Progr Cardiovasc Nursing, 10, 12
  41. Kelly, 1999, Medical restrictions to driving: the awareness of patients and doctors, Postgrad Med J, 75, 537, 10.1136/pgmj.75.887.537 · doi:10.1136/pgmj.75.887.537
  42. Conti, 1997, Modification of patient driving behavior after implantation of a cardioverter defibrillator, Pacing Clin Electrophysiol, 20, 2200, 10.1111/j.1540-8159.1997.tb04237.x · DOI · Paper page
  43. Trappe, 1998, Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period, J Interv Card Electrophysiol, 2, 193, 10.1023/A:1009763818159 · DOI
  44. Maas, 2003, Syncope, driving recommendations, and clinical reality: survey of patients, BMJ, 326, 21, 10.1136/bmj.326.7379.21 · DOI · Paper page
  45. Hickey, 2001, Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial, Am Heart J, 142, 99, 10.1067/mhj.2001.115787 · DOI
  46. Ostrom, 1987, Natural death while driving, J Forensic Sci, 32, 988, 10.1520/JFS12410J · DOI
  47. Hossack, 1974, Death at the wheel. A consideration of cardiovascular disease as a contributory factor to road accidents, Med J Aust, I, 164, 10.5694/j.1326-5377.1974.tb50782.x · DOI
  48. Parsons, 1986, Fits and other causes of loss of consciousness while driving, Q J Med, 58, 295, 10.1093/oxfordjournals.qjmed.a067959 · DOI
  49. Antecol, 1990, Sudden death behind the wheel from natural disease in drivers of four wheeled motor vehicles, Am J Cardiol, 66, 1329, 10.1016/0002-9149(90)91163-Z · DOI
  50. Ontario Ministry of Transportation., 1987, Ontario Road Safety Annual Report
  51. Freedberg, 2001, Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group, J Am Coll Card, 37, 1910, 10.1016/S0735-1097(01)01226-8 · DOI
  52. Levine, 1991, Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators, Circulation, 84, 558, 10.1161/01.CIR.84.2.558 · DOI
  53. Grimm, 1993, Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator, Am J Cardiol, 71, 1415, 10.1016/0002-9149(93)90602-9 · DOI
  54. Curtis, 1992, Time to first pulse after automatic implantable cardioverter defibrillator implantation, Ann Thorac Surg, 53, 984, 10.1016/0003-4975(92)90371-A · DOI
  55. Bansch, 1998, Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions, J Am Coll Cardiol, 31, 608, 10.1016/S0735-1097(97)00543-3 · DOI
  56. Tchou, 1991, When is it safe not to replace an implantable cardioverter defibrillator generator?, Pacing Clin Electrophysiol, 14, 1875, 10.1111/j.1540-8159.1991.tb02783.x · DOI
  57. Fogoros, 1989, Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator, Pacing Clin Electrophysiol, 12, 1465, 10.1111/j.1540-8159.1989.tb06151.x · DOI
  58. Lubinski, 2008, Potentially syncopal arrhythmias in ICD secondary prevention patients, Europace, 10, 233
  59. Kou, 1991, Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks, Ann Int Med, 115, 942, 10.7326/0003-4819-115-12-942 · DOI
  60. Freedberg, 2001, Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group, J Am Coll Cardiol, 37, 1910, 10.1016/S0735-1097(01)01226-8 · DOI
  61. Lerecouvreux, 2005, Automobile driving and implantable defibrillators, Arch Mal Coeur Vaiss, 98, 288
  62. Abello, 2006, Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia, Eur Heart J, 27, 89, 10.1093/eurheartj/ehi500 · DOI
  63. Conti, 1997, Modification of patient driving behavior after implantation of a cardioverter defibrillator, Pacing Clin Electrophysiol, 20, 2200, 10.1111/j.1540-8159.1997.tb04237.x · DOI · Paper page
  64. Curtis, 1995, Motor vehicle accidents in patients with an implantable cardioverter-defibrillator, J Am Coll Cardiol, 26, 180, 10.1016/0735-1097(95)00133-K · DOI · Paper page
  65. Alsheikh-Ali, 2008, Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy, J Cardiovasc Electrophysiol, 19, 784, 10.1111/j.1540-8167.2008.01111.x · DOI · Paper page
  66. Raviele, 1995, Italian multicenter clinical experience with endocardial defibrillation: acute and long-term results in 307 patients, Pacing Clin Electrophysiol, 18, 599, 10.1111/j.1540-8159.1995.tb02570.x · doi:10.1111/j.1540-8159.1995.tb02570.x
  67. Gold, 1997, Complications associated with pectoral implantation of cardioverter defibrillators, Pacing Clin Electrophysiol, 20, 208, 10.1111/j.1540-8159.1997.tb04844.x · DOI
  68. Fahy, 1995, Low incidence of lead related complications associated with nonthoracotomy implantable cardioverter defibrillator systems, Pacing Clin Electrophysiol, 18, 172, 10.1111/j.1540-8159.1995.tb02499.x · doi:10.1111/j.1540-8159.1995.tb02499.x
  69. Danik, 2008, Jude Riata lead: a single-center experience and a review of the literature, Heart Rhythm, 5, 1667, 10.1016/j.hrthm.2008.09.017 · doi:10.1016/j.hrthm.2008.09.017
  70. Ebstein, 2009, Performance of the St. Jude Medical Riata Leads, Heart Rhythm, 6, 204, 10.1016/j.hrthm.2008.10.030 · DOI
  71. Moss, 2004, Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator, Circulation, 110, 3760, 10.1161/01.CIR.0000150390.04704.B7 · DOI · Paper page
  72. Sesselberg, 2007, Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy, Heart Rhythm, 4, 1395, 10.1016/j.hrthm.2007.07.013 · DOI · Paper page
  73. Poole, 2008, Prognostic importance of defibrillator shocks in patients with heart failure, N Engl J Med, 359, 1009, 10.1056/NEJMoa071098 · DOI · Paper page
  74. Singh, 2005, Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation, J Am Coll Cardiol, 46, 1712, 10.1016/j.jacc.2005.05.088 · DOI · Paper page
  75. Daubert, 2008, Inappropriate implantable cardioverter-defibrillator shocks in MADIT II. Frequency, mechanisms, predictors, and survival impact, J Am Coll Cardiol, 51, 1357, 10.1016/j.jacc.2007.09.073 · DOI · Paper page
  76. Klein, 2003, Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial, J Cardiovasc Electrophysiol, 14, 940, 10.1046/j.1540-8167.2003.01554.x · DOI · Paper page
  77. Alter, 2005, Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients, Pacing Clin Electrophysiol, 28, 926, 10.1111/j.1540-8159.2005.00195.x · DOI · Paper page
  78. Sweeney, 2005, Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial, Circulation, 111, 2898, 10.1161/CIRCULATIONAHA.104.526673 · DOI · Paper page
  79. Lee, 2008, Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators, Circ J, 72, 102, 10.1253/circj.72.102 · DOI
  80. Tzeis, 2008, Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks, Europace, 10, 1256, 10.1093/europace/eun205 · doi:10.1093/europace/eun205
  81. Sacher, 2006, Outcome after implantation of a Cardioverter-defibrillator in patients with Brugada syndrome, Circulation, 114, 2317, 10.1161/CIRCULATIONAHA.106.628537 · DOI · Paper page
  82. Vanhees, 2004, Effect of exercise training in patients with an implantable cardioverter defibrillator, Eur Heart J, 25, 1120, 10.1016/j.ehj.2004.04.034 · DOI · Paper page
  83. Davids, 2005, Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey, Arch Phys Med Rehabil, 86, 1924, 10.1016/j.apmr.2005.04.009 · DOI
  84. Fitchet, 2003, Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial, Heart, 89, 155, 10.1136/heart.89.2.155 · DOI · Paper page

Cited by

See all 98

Metadata

Authors
Task force members, Vijgen, J., Botto, G., Camm, J., Hoijer, C.-J., Jung, W., Le Heuzey, J.-Y., Lubinski, A., Norekval, T. M., Santomauro, M., Schalij, M., Schmid, J.-P., & Vardas, P.
Venue
Europace
Published
2009-06-13
Volume
11
Issue
8
Pages
1097-1107
ISSN
  • 1099-5129 (ISSN-L)
  • 1532-2092
OpenAlex
W2153523473
Cited by
98
References
16
FWCI
4.94
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. https://app.cochat.ai/papers/10.1093/europace/eup112
The paper
Task force members, Vijgen, J., Botto, G., Camm, J., Hoijer, C.-J., Jung, W., Le Heuzey, J.-Y., Lubinski, A., Norekval, T. M., Santomauro, M., Schalij, M., Schmid, J.-P., & Vardas, P. (2009). Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace. https://doi.org/10.1093/europace/eup112

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.